Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
In the last 90 days, Bicycle Therapeutics PLC insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Bicycle Therapeutics PLC as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +5 vs. Q1 2026
- Shares held
- 37.3M
- −203.9K (−0.5%) vs. Q1 2026
- Total value
- $157.9M
- −$15.7M (−9.0%) vs. Q1 2026
- New holders
- 18
- 34 more added
- Sold out
- 13
- 18 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCYC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $157.9M |
| Q1 2026 | 98 | $173.6M |
| Q4 2025 | 109 | $276.9M |
| Q3 2025 | 99 | $285.6M |
| Q2 2025 | 110 | $286.3M |
| Q1 2025 | 95 | $354.4M |
| Q4 2024 | 97 | $586.5M |
| Q3 2024 | 105 | $915.3M |
| Q2 2024 | 107 | $804.0M |
| Q1 2024 | 95 | $759.1M |
| Q4 2023 | 101 | $567.4M |
| Q3 2023 | 101 | $651.3M |
| Q2 2023 | 85 | $618.5M |
| Q1 2023 | 89 | $498.9M |
| Q4 2022 | 87 | $695.9M |
| Q3 2022 | 79 | $538.0M |
| Q2 2022 | 82 | $381.1M |
| Q1 2022 | 105 | $884.5M |
| Q4 2021 | 101 | $1.31B |
| Q3 2021 | 69 | $591.1M |
| Q2 2021 | 54 | $376.9M |
| Q1 2021 | 39 | $341.2M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Bicycle Therapeutics PLC; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,398,000 | $14.4M | 0.40% | 00.0% | Unchanged |
| FCPM III Services B.V. | 3,468,430 | $14.7M | 1.96% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 10,885,357 | $46.2M | 0.23% | 00.0% | Unchanged |
| Siren, L.L.C. | 0 | $0 | 0.00% | −1,560,882−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −1,174,625−100.0% | Sold out |
| Silvercrest Asset Management Group LLC | 0 | $0 | 0.00% | −428,684−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −184,603−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −115,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −63,305−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −35,400−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −21,057−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −14,317−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,879−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −9,054−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −5−100.0% | Sold out |